Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 19.69% is 64% below its 5-year average of 54.96%, near the low end of its 5-year range (8.49%–90.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 64.16% below its 12-month average of 54.94%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 19.69%.
DEBT TO ASSETS RATIO
19.69%
DEBT TO ASSETS RATIO AVG TTM
54.94%
DEBT TO ASSETS RATIO AVG 3Y
75.87%
DEBT TO ASSETS RATIO AVG 5Y
54.96%
DEBT TO ASSETS RATIO AVG 10Y
29.42%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-64.16%
CURRENT VS 3Y AVG
-74.05%
CURRENT VS 5Y AVG
-64.17%
CURRENT VS 10Y AVG
-33.09%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.13%
median of 341 covered companies
CURRENT VS SECTOR MEDIAN
+15044.70%
vs the sector median at left
Ascendis Pharma A/S
Market Cap
$14.16B
Debt to Assets Ratio
19.69%
TTM Avg
54.94%
3Y Avg
75.87%
5Y Avg
54.96%
Market Cap
$14.97B
Debt to Assets Ratio
0.40%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.19B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.24B
Debt to Assets Ratio
0.37%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.95B
Debt to Assets Ratio
2.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.89B
Debt to Assets Ratio
0.21%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.52B
Debt to Assets Ratio
0.49%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ascendis Pharma A/S (ASND) | $14.16B | 19.69% | 54.94% | 75.87% | 54.96% |
| Tempus AI, Inc. (TEM)vs › | $14.64B | 0.61% | N/A | N/A | N/A |
| Exelixis, Inc. (EXEL)vs › | $14.79B | 0.07% | N/A | N/A | N/A |
| Charles River Laboratories International, Inc. (CRL)vs › | $14.97B | 0.40% | N/A | N/A | N/A |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 0.01% | N/A | N/A | N/A |
| Solventum Corporation (SOLV)vs › | $15.24B | 0.37% | N/A | N/A | N/A |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | 2.05% | N/A | N/A | N/A |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 0.21% | N/A | N/A | N/A |
| Baxter International Inc. (BAX)vs › | $12.52B | 0.49% | N/A | N/A | N/A |
| Penumbra, Inc. (PEN)vs › | $12.49B | 0.11% | N/A | N/A | N/A |
Debt/Assets
19.7%
Debt/Equity
0.31
Current Ratio
2.99
Interest Coverage
-1.7x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 19.69% |
| 2026-03-31 | 44.76% |
| 2025-12-31 | 66.93% |
| 2025-09-30 | 70.46% |
| 2025-06-30 | 72.85% |
| 2025-03-31 | 79.82% |
| 2024-12-31 | 72.63% |
| 2024-09-30 | 72.10% |
| 2024-06-30 | 88.70% |
| 2024-03-31 | 83.37% |
| 2023-12-31 | 90.00% |
| 2023-09-30 | 76.25% |
| 2023-06-30 | 61.41% |
| 2023-03-31 | 52.30% |
| 2022-12-31 | 46.65% |
| 2022-09-30 | 43.45% |
| 2022-06-30 | 38.60% |
| 2022-03-31 | 34.39% |
| 2021-12-31 | 19.35% |
| 2021-09-30 | 8.49% |
| 2021-06-30 | 11.86% |
| 2021-03-31 | 9.99% |
| 2020-12-31 | 9.39% |
| 2020-09-30 | 3.18% |
| 2020-06-30 | 6.33% |
| 2020-03-31 | 5.97% |
| 2019-12-31 | 5.41% |
| 2019-09-30 | 5.02% |
| 2019-06-30 | 4.73% |
| 2019-03-31 | 2.29% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2013-12-31 | 0.00% |
